Retained Earnings (Accumulated Deficit) of DA32 Life Science Tech Acquisition Corp. from 30 Sep 2021 to 31 Mar 2023

Taxonomy & unit: us-gaap: USD
Description: The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary: DA32 Life Science Tech Acquisition Corp. quarterly Retained Earnings (Accumulated Deficit) in USD history and change rate from 30 Sep 2021 to 31 Mar 2023.
DA32 Life Science Tech Acquisition Corp. Retained Earnings (Accumulated Deficit) for the quarter ending 31 Mar 2023 was $5,109,260, a 38% decline year-over-year.
Source SEC data: View on sec.gov

Retained Earnings (Accumulated Deficit), Quarterly (USD)

Retained Earnings (Accumulated Deficit), YoY Quarterly Change (%)

DA32 Life Science Tech Acquisition Corp. Quarterly Retained Earnings (Accumulated Deficit) (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q1 2023	$5,109,260	-$1,411,744	-38%	31 Mar 2023	10-Q	12 May 2023	2023	Q1
Q4 2022	$4,736,400	-$1,342,248	-40%	31 Dec 2022	10-Q	12 May 2023	2023	Q1
Q3 2022	$4,400,052	-$1,263,054	-40%	30 Sep 2022	10-Q	10 Nov 2022	2022	Q3
Q2 2022	$4,164,813			30 Jun 2022	10-Q	15 Aug 2022	2022	Q2
Q1 2022	$3,697,516			31 Mar 2022	10-Q	13 May 2022	2022	Q1
Q4 2021	$3,394,152			31 Dec 2021	10-K	29 Mar 2023	2022	FY
Q3 2021	$3,136,998			30 Sep 2021	10-Q	15 Nov 2021	2021	Q3

* An asterisk sign (*) next to the value indicates that the value is likely invalid.